Cargando…
The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review
BACKGROUND: Since 2010, the Blood Center of Zhejiang province, China, has conducted a pilot nucleic acid amplification testing (NAT) screening of blood donors for Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Human immunodeficiency virus (HIV). This study aims to assess the results of NAT te...
Autores principales: | Wu, Danxiao, Feng, Fangjun, Wang, Xiaojuan, Wang, Dairong, Hu, Yiqin, Yu, Yang, Huang, Jihong, Wang, Min, Dong, Jie, Wu, Yaling, Zhu, Hong, Zhu, Faming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943971/ https://www.ncbi.nlm.nih.gov/pubmed/35321684 http://dx.doi.org/10.1186/s12879-022-07279-5 |
Ejemplares similares
-
Characteristic of HBV nucleic acid amplification testing yields from blood donors in China
por: Wu, Danxiao, et al.
Publicado: (2021) -
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
por: Shyamala, Venkatakrishna
Publicado: (2014) -
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
por: Kumar, Rajesh, et al.
Publicado: (2015) -
Individual donation nucleic acid technology testing to minimize human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus transfusion transmitted infections
por: Shyamala, Venkatakrishna, et al.
Publicado: (2014) -
Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment
por: Shahriar, Sagarika, et al.
Publicado: (2022)